INTRODUCTION AND OBJECTIVES:
The optimal time frame for definitive stone treatment in stented patients after an event of urosepsis is not well defined. Objective: to evaluate clinical parameters, bacteriology and risk factors for an event of recurrent infection in stented patients following a septic event prior to definite treatment for ureterolithiasis.
METHODS: The records of 176 patients who presented with urosepsis and ureterolithiasis between 2009-2017 and primarily drained with a DJ stent, were reviewed. A comparison was carried out between 129 patients with no additional medical or surgical events while awaiting definitive treatment and 47 patients (27%) who experienced an even of recurrent infection prior to definitive stone treatment.
RESULTS: 47/176 (27%) stented patients experienced additional infectious event. 47% of patients with recurrent infection present within 4 weeks following the primary septic episode. Mortality: one case (0.8%) during the primary episode and three cases (6.3%) during re-admission.
Most common pathogens isolated from urinary samples during the primary septic episode were E.Coli (19%), Proteus Mirabilis (7.2%), Enterococus Faecalis (5.8%) and Klabsiella pneumonia (4.8%). 28% (49/ 176) had positive blood cultures. In 9.7% of patients resistant bacteria grew in the urine (Pseudomonas A, Acinetobacter baumani, ESBL positive E.Coli/ Klabsiella P/ Proteus M). During recurrent infection, there was more than a threefold increase in resistant bacteria culture growth. 57% of patients with recurrent infection had a change in urinary bacterial growth or acquired multibacterial growth in comparison to their primary hospitalization
The presence of hypertension (p[0.03), CKD (p[0.05), hyperglycemia (p[0.02), AKI (p[0.001) and deferred diagnosis of sepsis (p[0.01) in the first admission were found to be independent risk factors for recurrent infection. In a multivariate analysis significant odds ratio for recurrent infection were obtained for AKI (OR 1.41, p[0.002) and hyperglycemia (OR 2.05, p[0.048) .
CONCLUSIONS: Patients with AKI or hyperglycemia during initial hospitalization are at risk for recurrent infection after drainage with DJ stent for urosepsis associated with ureterolithiasis. During the period between drainage and definite stone treatment, an episode of recurrent infection is associated with an increased risk of resistant bacteria and mortality. It is pertinent that the optimal timing for definite stone treatment in this specific subset of patient will be studied in prospective study.
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MP12-11 DIETARY ALTERNATIVES TO PRESCRIPTION POTASSIUM CITRATE
Tim Large*, James Williams, INDIANAPOLIS, IN; Ignacio Granga, John Asplin, Chicago, IL; Amy Krambeck, INDIANAPOLIS, IN INTRODUCTION AND OBJECTIVES: Potassium citrate is the primary therapy for recurrent stone formers with hypocitraturia and aciduria. Gastrointestinal side effects, large pill size, and frequent dosing and cost of the medication have limited patient compliance. The goal of our study was to identify a low calorie beverage that can adequately alkalinize human urine METHODS: Ion chromatography was used to evaluate the available alkali and citrate content of 5 beverages. The best performers were then utilized in a prospective randomized cross over trial involving 10 volunteers without a history of nephrolithiasis. Over 8 weeks volunteers drank 2L of water or 1L of water and 1L of crystal light lemon (CCLF), Kroger brand low-cal OJ (KROG), or Tropicana50 OJ (TRP50). Participants were given a random drink order and did a washout week between trial beverages. After a trial week participants would complete a 24-hr urine collection which was evaluated by Litholink laboratories. Participants were asked to keep their diet and exercise regimen the same each trial week and to keep a detailed diet and symptom journal. Statistical analysis involved a one-way ANOVA comparison of means.
RESULTS: The chemical analyses in Table 1 show that both low-cal OJ's (KROG/TRP50) have equivalent alkali (140 & 158 vs 165 mEq/L) but with half the sugar content compared to regular OJ. In a paired match analysis with water consumption as the control, changes in 24-hr urine volume and pH was statistically higher with KROG compared to CLLF, TRP50 with collective average pH 6.93, 6.63, 6.44 respectively. Low volume with TRP50 corresponded with dietary journals of 7/10 patients who reported GI issues with TRP50 (perhaps from the sweetener used).
CONCLUSIONS: Low-cal OJ can alkalinize urine; however, the palatability of beverage is equally important to the alkali potential of the beverage. CLLF should also be recommended as an alkalinizing dietary alternative.
